Search results for "RENAL FUNCTION"

showing 10 items of 381 documents

Unfavourable interaction of microalbuminuria and mildly reduced creatinine clearance on aortic stiffness in essential hypertension

2010

The aim of our study was to assess the independent relationships of urinary albumin excretion rate (AER), of creatinine clearance (CrCl) and of their interaction with aortic stiffness in hypertensive patients without overt renal insufficiency. We studied 222 untreated nondiabetic essential hypertensives. In patients with reliable 24-h urine collections, AER and CrCl were determined. Microalbuminuria (MAU) was defined as an AER of 20 to 200microg/min. Aortic stiffness was assessed by measurement of carotid-femoral pulse wave velocity (c-f PWV). C-f PWV was higher in subjects with MAU than in those without it (p<0.001, even after adjustment for age, sex and mean arterial pressure) and in subj…

Mean arterial pressuremedicine.medical_specialtyRenal functionArteriosclerosiEssential hypertensionchemistry.chemical_compoundInternal medicinemedicineAlbuminuriaPulse wave velocityCreatininebusiness.industrymedicine.diseaseMild renal dysfunctionArterial stiffnePulse wave velocityEndocrinologychemistryHypertensioncardiovascular systemArterial stiffnessCardiologyMicroalbuminuriaAortic stiffnessCardiology and Cardiovascular Medicinebusiness
researchProduct

Serum Copeptin and Midregion Proadrenomedullin (MR-proADM) After an Ultramarathon

2014

Background Although it is widely acknowledged that physical activity confers several health benefits, it remains uncertain whether strenuous and physically demanding exercise might determine biological effects that might turn to be ultimately unfavorable for health. Copeptin and midregion proadrenomedullin (MR-proADM) are emerging cardiovascular and stress biomarkers, but little is known about the influence of strenuous physical exercise on their concentrations. Methods The present study was performed to investigate the variation of copeptin and MRproADM, along with that of serum creatinine and estimated glomerular filtration rate before and after a 60 km ultramarathon in 16 healthy Caucasi…

Microbiology (medical)medicine.medical_specialtyClinical BiochemistryPopulationRenal functionPhysical exerciseReference rangeHealth benefitschemistry.chemical_compoundCopeptinInterquartile rangeInternal medicineImmunology and AllergyMedicineeducationeducation.field_of_studyCreatininebusiness.industryBiochemistry (medical)Public Health Environmental and Occupational HealthHematologyMedical Laboratory TechnologyEndocrinologychemistryCardiologybusinessJournal of Clinical Laboratory Analysis
researchProduct

Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project

2021

Abstract Background Hyperuricemia is commonly observed in patients with chronic kidney disease (CKD). However, a better understanding of the relationship among uric acid (UA) values, glomerular filtration rate (GFR) and albuminuria may shed light on the mechanisms underlying the excess of cardiovascular mortality associated with both chronic kidney disease and hyperuricemia and lead to better risk stratification. Our main goal was to study the relationships between serum uric acid and kidney disease measures (namely estimated GFR [eGFR] and albuminuria) in a large cohort of individuals at cardiovascular risk from the URic acid Right for heArt Health (URRAH) Project database. Methods Clinica…

NephrologyAdultMalemedicine.medical_specialtySettore MED/09 - Medicina Interna030232 urology & nephrologyAllopurinolRenal functionHyperuricemia030204 cardiovascular system & hematologyKidneyurologic and male genital diseasesGastroenterology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSerum uric acidRisk FactorsInternal medicineDiabetes mellitusmedicineeGFRHumansAlbuminuriaHyperuricemiaRenal Insufficiency ChronicAgedbusiness.industryAlbuminuria; Cardiovascular risk; Serum uric acid; eGFRnutritional and metabolic diseaseseGFR.Middle Agedmedicine.diseaseCardiovascular riskUric AcidchemistryNephrologyAlbuminuriaUric acidAlbuminuria; Cardiovascular risk; eGFR; Serum uric acidOriginal ArticleFemalemedicine.symptombusinessmedicine.drugKidney diseaseGlomerular Filtration Rate
researchProduct

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.

2011

Recent studies have shown that both glomerular and tubulointerstitial damage are important factors in the pathophysiology and progression of diabetic nephropathy. To examine whether markers of tubular damage are useful in monitoring the progression of disease, we measured urinary levels of neutrophil gelatinase-associated lipocalin (NGAL), liver-fatty acid-binding protein (LFABP), and kidney injury molecule-1 (KIM-1) in a 3-year intervention study of 63 type 1 diabetic patients with kidney disease. The baseline mean glomerular filtration rate (GFR) was 87 ml/min per 1.73 m(2) and urinary albumin excretion 1141 mg/24 h. Patients with the highest compared with the lowest quartile of urinary N…

NephrologyAdultMalemedicine.medical_specialtyUrinary systemUrologyRenal functiontubule cellsFatty Acid-Binding ProteinsLosartanDiabetic nephropathyLipocalin-2Internal medicineDiabetes mellitusProto-Oncogene ProteinsMedicineHumansDiabetic NephropathiesHepatitis A Virus Cellular Receptor 1Type 1 diabetesKidneyMembrane Glycoproteinsbusiness.industrydiabetic nephropathyMiddle Agedmedicine.diseaseLipocalinsEndocrinologymedicine.anatomical_structureDiabetes Mellitus Type 1Nephrologydiabetes mellitusReceptors VirusFemalebusinessBiomarkersKidney diseaseAcute-Phase ProteinsGlomerular Filtration RateKidney international
researchProduct

Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.

2007

&lt;i&gt;Background/Aim:&lt;/i&gt; Type 2 diabetes mellitus is the single most common cause of chronic kidney disease (CKD); however its real impact on renal anaemia has not been established. The aim of this study was to evaluate whether onset, severity, and prevalence of anaemia during the course of CKD is different between type 2 diabetic and non-diabetic patients. &lt;i&gt;Methods:&lt;/i&gt; We enrolled 281 patients with: (1) type 2 diabetes and no CKD (n = 75); (2) type 2 diabetes plus CKD (n = 106), and (3) CKD without type 2 diabetes (n = 100). According to K/DOQI guidelines, the patients with renal insufficiency (i.e., those with a glomerular filtration rate &lt;60 ml/min) were subgr…

NephrologyMaleglomerulus filtration rateType 2 diabetesurologic and male genital diseasesGastroenterologySeverity of Illness Indexadult; aged; anemia; article; chronic kidney failure; comparative study; controlled study; creatinine clearance; diabetic nephropathy; disease course; disease severity; female; glomerulus filtration rate; hemoglobin blood level; human; kidney failure; kidney function; major clinical study; male; non insulin dependent diabetes mellitus; practice guideline; prevalence; priority journal; risk assessment; Aged; Anemia; Creatinine; Diabetes Mellitus Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Kidney Failure Chronic; Male; Middle Aged; Prevalence; Severity of Illness Index; Sex DistributionKidney FailureDiabetic nephropathychemistry.chemical_compoundHemoglobinsChronic kidney diseasecreatinine clearancePrevalenceDiabetic NephropathiesChronickidney functioncomparative studynon insulin dependent diabetes mellitusadultdisease coursearticlerisk assessmentAnemiaGeneral Medicinechronic kidney failureMiddle Agedpriority journalNephrologyCreatininedisease severityFemaleType 2Glomerular Filtration Ratemedicine.medical_specialtyAnaemia diabetes mellitus; Chronic kidney disease diabetes mellitus; Type 2 diabetes mellitus anaemiaRenal functionAnaemiaDiabetes mellitusInternal medicineType 2 diabetes mellitusDiabetes MellitusmedicineHumanscontrolled studyhumanSex DistributionAgedSettore MED/14 - NefrologiaCreatininehemoglobin blood levelbusiness.industrydiabetic nephropathypractice guidelineType 2 Diabetes Mellitusmedicine.diseasemajor clinical studySurgerychemistryDiabetes Mellitus Type 2Kidney Failure ChronicbusinessKidney disease
researchProduct

Double-J stent insertion across vesicoureteral junction--is it a valuable initial approach in neonates and infants with severe primary nonrefluxing m…

2006

Abstract Objectives To evaluate the role of double- J stent insertion in perinatally detected primary nonrefluxing megaureters as a method to temporize treatment in patients with impaired renal function or to prevent function loss in patients treated expectantly, but deemed at high risk of deterioration. Methods Two neonates and 8 infants with a ureter greater than 10 mm and an obstructive excretion pattern, including 3 cases with renal function less than 40%, were selected to undergo double- J stent insertion for a 6-month period. Patients underwent surgery if the ureter redilated and the excretion pattern was obstructive at reassessment 3 months after stent removal. Results Stents were pl…

NephrologyMalemedicine.medical_specialtyMegaureterUrologyUrinary systemmedicine.medical_treatmentUrinary BladderRenal functionUreterInternal medicinemedicineHumansUreteral DiseasesVesico-Ureteral RefluxUrinary bladderbusiness.industryUrinary retentiondouble-J stent megaureter pediatricsInfant NewbornStentInfantUrinary Retentionmedicine.diseaseSurgerymedicine.anatomical_structureUrologic Surgical ProceduresFemaleStentsmedicine.symptomUreterbusinessUrology
researchProduct

Renal tumour surgery in elderly patients.

2008

OBJECTIVE To analyse morbidity, renal function and oncological outcome in patients aged ≥80 years who had surgery for renal tumours, as in the elderly such surgery is controversial in relation to life-expectancy and other causes of death. PATIENTS AND METHODS Between 1990 and 2006, in our institution 1625 patients had surgery to treat solid renal tumours suspected to be renal cell carcinoma (RCC); 62 (4%) were aged ≥80 years (mean 82.5), and 73% of these elderly patients had radical nephrectomy (RN) and 27% nephron-sparing surgery (NSS). Results The median (range) follow-up was 3.1 (0.2–14.1) years (89% of the patients). There was no perioperative mortality. There were only minor complicati…

NephrologyMalemedicine.medical_specialtyUrologymedicine.medical_treatmentRenal functionurologic and male genital diseasesNephrectomyDisease-Free SurvivalPostoperative ComplicationsRenal cell carcinomaInternal medicineMedicineHumansCarcinoma Renal CellSurvival analysisNeoplasm StagingRetrospective StudiesAged 80 and overbusiness.industryAge FactorsPerioperativemedicine.diseasePrognosisSurvival AnalysisNephrectomyKidney NeoplasmsSurgeryTreatment OutcomeFemalebusinessKidney cancerKidney diseaseFollow-Up StudiesBJU international
researchProduct

PARA-PERIRENAL DISTRIBUTION OF BODY FAT IS ASSOCIATED WITH REDUCED GLOMERULAR FILTRATION RATE REGARDLESS OF OTHER INDICES OF ADIPOSITY IN HYPERTENSIV…

2018

INTRODUCTION: Obesity is a well-known risk factor for the development and progression of chronic kidney disease. Recently, para-perirenal ultrasonographic fat thickness (PUFT) has shown to correlate with both total and visceral fat better than body mass index (BMI), waist circumference (WC) and other indices of obesity. Moreover, a local paracrine and mechanical action of the PUFT on kidney has been described in recent studies. AIM: To assess the relationship between glomerular filtration rate (GFR) and PUFT in comparison to other anthropometric and ultrasonographic indices of adiposity. METHODS: Two hundred ninety-six hypertensive patients were enrolled. PUFT, cutis-rectis thickness and re…

Obesity - Renal function - Ecograpphy -
researchProduct

Population pharmacokinetic model of lithium and drug compliance assessment.

2016

Population pharmacokinetic analysis of lithium during therapeutic drug monitoring and drug compliance assessment was performed in 54 patients and 246 plasma concentrations levels were included in this study. Patients received several treatment cycles (1-9) and one plasma concentration measurement for each patient was obtained always before starting next cycle (pre-dose) at steady state. Data were analysed using the population approach with NONMEM version 7.2. Lithium measurements were described using a two-compartment model (CL/F=0.41Lh-1, V1/F=15.3L, Q/F=0.61Lh-1, and V2/F = 15.8L) and the most significant covariate on lithium CL was found to be creatinine clearance (reference model). Lith…

OncologyAdultMalemedicine.medical_specialtyBipolar DisorderPopulationPopulationchemistry.chemical_elementRenal functionBiological AvailabilityLithium030226 pharmacology & pharmacy03 medical and health sciencesYoung Adult0302 clinical medicinePharmacokineticsAntimanic AgentsInternal medicineStatisticsCovariateMedicineHumansPharmacology (medical)educationBiological PsychiatryPharmacologyeducation.field_of_studyModels Statisticalmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryMiddle AgedMarkov ChainsNONMEMBioavailabilityPsychiatry and Mental healthNeurologychemistryTherapeutic drug monitoringLithium CompoundsPatient ComplianceLithiumFemaleNeurology (clinical)Drug Monitoringbusiness030217 neurology & neurosurgeryEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adul…

2019

Introduction: This article comprehensively reviews the clinical utility of the serum clozapine/norclozapine (CLO/NCLO) ratio. Areas covered: Fifty-four published studies used this ratio (21 from a PubMed search from onset to 10/21/18 and 33 identified by the authors). To estimate a combined mean of the CLO/NCLO ratio in published studies, a PubMed search on 10/21/18 identified 422 articles leading to 19 included. The systematic review focused on 1) the combined analysis, 2) CYP1A2 activity, 3) clinical response, 4) cognition, and 5) renal function. Expert opinion: Our combined analysis provided a weighted mean CLO/NCLO ratio of 1.73 in 2,317 adult patients from 19 studies, but the range in …

OncologyAdultmedicine.medical_specialtyClozapine+NorclozapineRenal function030226 pharmacology & pharmacylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineGemfibrozilAnimalsHumansPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsClozapineClozapineRandomized Controlled Trials as TopicAdult patientsmedicine.diagnostic_testbusiness.industryGeneral MedicineTherapeutic drug monitoring030220 oncology & carcinogenesisDrug MonitoringbusinessRenal transportersmedicine.drugAntipsychotic AgentsExpert review of clinical pharmacology
researchProduct